2/20
09:45 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
2/20
09:45 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
2/19
04:20 pm
biib
Biogen initiated with an Equal Weight at Barclays
Low
Report
Biogen initiated with an Equal Weight at Barclays
2/19
04:20 pm
biib
Biogen initiated with an Equal Weight at Barclays
Low
Report
Biogen initiated with an Equal Weight at Barclays
2/10
09:42 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
2/10
09:42 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
2/9
03:17 pm
biib
Rating for BIIB
Low
Report
Rating for BIIB
2/9
02:36 pm
biib
Rating for BIIB
Low
Report
Rating for BIIB
2/9
01:00 pm
biib
Rating for BIIB
Low
Report
Rating for BIIB
2/9
01:00 pm
biib
Rating for BIIB
Low
Report
Rating for BIIB
2/9
11:05 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
2/9
11:05 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
2/9
09:58 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
2/9
09:58 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
2/9
09:47 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
2/9
09:47 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
2/9
09:07 am
biib
Rating for BIIB
Medium
Report
Rating for BIIB
2/9
09:07 am
biib
Rating for BIIB
Medium
Report
Rating for BIIB
2/9
07:57 am
biib
Rating for BIIB
Medium
Report
Rating for BIIB
2/9
07:57 am
biib
Rating for BIIB
Medium
Report
Rating for BIIB
2/9
07:20 am
biib
Biogen (NASDAQ:BIIB) had its "market perform" rating reaffirmed by analysts at Sanford C. Bernstein.
Medium
Report
Biogen (NASDAQ:BIIB) had its "market perform" rating reaffirmed by analysts at Sanford C. Bernstein.
2/9
07:20 am
biib
Biogen (NASDAQ:BIIB) had its "buy" rating reaffirmed by analysts at Guggenheim.
Medium
Report
Biogen (NASDAQ:BIIB) had its "buy" rating reaffirmed by analysts at Guggenheim.
2/9
07:20 am
biib
Biogen (NASDAQ:BIIB) had its "buy" rating reaffirmed by analysts at Guggenheim.
Medium
Report
Biogen (NASDAQ:BIIB) had its "buy" rating reaffirmed by analysts at Guggenheim.
2/6
04:04 pm
biib
Biogen (NASDAQ:BIIB) had its "market perform" rating reaffirmed by analysts at BMO Capital Markets.
Medium
Report
Biogen (NASDAQ:BIIB) had its "market perform" rating reaffirmed by analysts at BMO Capital Markets.
1/30
11:18 am
biib
Rating for BIIB
Low
Report
Rating for BIIB